Similar effects were observed with neural stem cell or bone marrow stromal cell injections
Research Applications Lipolysis Mechanism Investigation AOD9604 serves as a research tool for investigating 3-adrenergic-receptor-dependent lipolytic pathways: Hormone-Sensitive Lipase: Examination of HSL activation, phosphorylation status, and lipid droplet association ATGL Regulation: Research on adipose triglyceride lipase expression and activity modulation Perilipin Phosphorylation: Investigation of lipid droplet coating protein regulation 3-Adrenergic Receptor Dependence: Studies indicating AOD9604s lipolytic effect requires functional 3-adrenergic receptors (abolished in 3-AR knockout models) and is associated with increased 3-AR expression Signaling Cascades: Examination of kinase cascades, calcium signaling, and downstream effectors Research protocols investigate how AOD9604 stimulates lipolysis through mechanisms distinct from catecholamines, providing insights into alternative fat mobilization pathways
This approach maintains more consistent beta-3 receptor stimulation throughout the 24-hour period
[9] [2] According to NICE guidance, patients with confirmed B12 deficiency and neurological involvement typically require more frequent initial dosing (alternate-day injections) until symptom improvement occurs
Personalized Nutritional Recommendations: You get personalized recommendations for amino acids, fatty acids, vitamins, minerals, and digestive support
But beyond weight loss, AOD 9604 offers other benefits, including: AOD 9604 was originally developed to treat obesity, but today, many people use it as a weight-loss treatment
